Yixin Yang

Dr. Yixin Yang

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2016 in Integrative Cancer Therapies
Verified
Journal Article
Open access
YZYunqi Zhao
Yunqi Zhao
RCRan Chen
Ran Chen
YWYun Wang
Yun Wang
CQChen Qing
Chen Qing
WWWei Wang
Wei Wang
YYYixin Yang
Yixin Yang
Lavandula angustifolia is the most widely cultivated Lavandula species. The extraction of its flower and leaves has been used as herbal medicine. In this study, the in vitro antitumor activities were tested on human prostate cancer PC-3 and DU145 cell lines. Flow cytometry technology was applied to study apoptosis induction and cell cycle arrest. The PC-3 cell line was used to establish subcutaneous xenograft tumors in nude mice. Paraffin sections from xenograft tumor specimens were used in the TUNEL (terminal deocynucleotide transferase dUTP nick end labeling) assay and an immunohistochemistry assay to detect cell proliferation markers Ki67 and PCNA. Lavender essential oil, linalool, and linalyl acetate showed stronger inhibitory effect on PC-3 cells than on DU145 cells. The apoptotic cell populations observed in PC-3 cells treated with lavender essential oil, linalool, and linalyl acetate were 74.76%, 67.11%, and 56.14%, respectively. The PC-3 cells were mainly arrested in the G2/M phase. In the xenograft model with PC-3 cell transplantation, essential oil and linalool significantly suppressed tumor growth. The immunosignals of Ki67 and PCNA in the essential oil, linalool, and linalyl acetate treatment groups were significantly lower than that of the control group in xenograft tumor sections. The TUNEL assay indicated that each of the 3 phytochemicals significantly induced apoptosis compared to the control group. This study provides novel insight and evidence on the antiproliferative effect of L angustifolia essential oil and its major constituents on human prostate cancer. The antitumor effect was associated with cell proliferation inhibition and apoptosis induction in xenograft tumors.

30 March 2017 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
GYGuang Yang
Guang Yang
YYYao Yan
Yao Yan
YMYounan Ma
Younan Ma
YYYixin Yang
Yixin Yang

10 July 2017 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
HQHui Qian
Hui Qian
CYChen Yang
Chen Yang
YYYixin Yang
Yixin Yang
Metastatic melanoma is the most aggressive form of skin cancer and is refractory to therapy. MicroRNAs have been recently discovered as novel molecules that provide therapeutic benefits against melanoma. This work aims to examine the effects of miR-26a and let-7a on the growth and invasiveness of malignant melanomain vitroandin vivo. In addition, we elucidate the mechanism of action by identifying the target gene of miR-26a. Both miR-26a and let-7a inhibited proliferation and invasiveness and halted the cell cycle at the G1/G0phase in SKMEL-28 and WM1552C malignant melanoma cell lines. Moreover, miR-26a potently induced apoptosis and downregulated the expressions ofmicrophthalmia-associated transcription factor (MITF)and MAP4K3 in both cell lines. The luciferase reporter assay demonstrated that miR-26a suppresses MITF expression by binding the 3′-UTR, suggesting that MITF is abona fidetarget of miR-26a. SiRNA knockdown of theMITFgene confirmed that miR-26a reduced cell viability and induced apoptosis by regulating MITF. Using a murine model, we also found miR-26a significantly retarded the growth of melanoma tumorsin vivo. In conclusion, miR-26a and let-7a suppressed the growth and invasiveness of melanoma cells, suggesting that miR-26a and let-7a may represent novel therapies for malignant melanoma.

Verified
Journal Article
Open access
PDF file
LDLinyinxue Dong
Linyinxue Dong
Xuechen TianXuechen Tian
Xuechen Tian
YZYunqi Zhao
Yunqi Zhao
HTHaohong Tu
Haohong Tu
AWAloysius Wong
Aloysius Wong
YYYixin Yang
Yixin Yang
Melanoma is the most aggressive form of skin cancer, characterized by life-threatening and rapidly spreading progression. Traditional targeted therapy can alleviate tumors by inactivating hyperactive kinases such as BRAF or MEK but inevitably encounters drug resistance. The advent of immunotherapy has revolutionized melanoma treatment and significantly improved the prognosis of melanoma patients. MicroRNAs (miRNAs) are intricately involved in innate and adaptive immunity and are implicated in melanoma immunotherapy. This systematic review describes the roles of miRNAs in regulating the functions of immune cells in skin and melanoma, as well as the involvement of miRNAs in pharmacology including the effect, resistance and immune-related adverse events of checkpoint inhibitors such as PD-1 and CTLA-4 inhibitors, which are used for treating cutaneous, uveal and mucosal melanoma. The expressions and functions of miRNAs in immunotherapy employing tumor-infiltrating lymphocytes and Toll-like receptor 9 agonists are also discussed. The prospect of innovative therapeutic strategies such as the combined administration of miRNAs and immune checkpoint inhibitors and the nanotechnology-based delivery of miRNAs are also provided. A comprehensive understanding of the interplay between miRNAs and immunotherapy is crucial for the discovery of reliable biomarkers and for the development of novel miRNA-based therapeutics against melanoma.

4 August 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
CAChristopher Alderman
Christopher Alderman
ASAyoub Sehlaoui
Ayoub Sehlaoui
ZXzhaoyang xiao
zhaoyang xiao
YYYixin Yang
Yixin Yang

14 September 2023 in Nature Plants
Verified
Journal Article
Closed access
PDF file
AWAloysius Wong
Aloysius Wong
WCWei Chi
Wei Chi
JYJia Yu
Jia Yu
CBChuyun Bi
Chuyun Bi
Xuechen TianXuechen Tian
Xuechen Tian
CGChris Gehring
Chris Gehring